Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00835055

Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
St. Claraspital AG · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Conditions

Timeline

Start date
2005-04-01
Primary completion
2019-04-01
Completion
2019-04-01
First posted
2009-02-03
Last updated
2019-04-05

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00835055. Inclusion in this directory is not an endorsement.

Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer (NCT00835055) · Clinical Trials Directory